Lehrstuhl für Innere Medizin III


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

THE 4-D+ NANOSCOPE: THE RESOLUTION FOR BIOLOGICAL SAMPLES (2019) Kling L, Mill L, Grüneboom A, Sarau G, Herrmann M, Schett G, Maier A, Christiansen SH Conference contribution A SET OF INFLAMMATORY MARKERS ALLOWING TO DETECT SYSTEMIC INFLAMMATION IN PSORIATIC SKIN, ENTHESEAL AND JOINT DISEASE IN THE ABSENCE OF CRP AND THEIR LINK TO CLINICAL DISEASE MANIFESTATION (2019) Sokolova M, Nas K, Luo Y, Simon D, Zhao Y, Rech J, Zaiss M, Schett G Conference contribution IMPACT OF PRIMARY HAND OSTEOARTHRITIS ON MICROSTRUCTURE AND BIOMECHANICS IN FINGER JOINTS (2019) Simon D, Tascilar K, Unbehend S, Bayat S, Meinderink T, Berlin A, Rech J, et al. Conference contribution MICRO-STRUCTURAL CHANGES ASSOCIATED WITH ANTI-CITRULLINATED VIMENTIN AUTOIMMUNITY IN RA-AT-RISK INDIVIDUALS PRECIPITATE THE ONSET OF RHEUMATOID ARTHRITIS (2019) Kleyer A, Simon D, Bui CD, Hueber A, Bang H, Rech J, Krönke G, et al. Conference contribution IMPORTANT ROLE OF CD11C+CELLSIN INFLAMMATORY ARTHRITIS (2019) Puchner A, Simader E, Saferding V, Krönke G, Pfeifle R, Aletaha D, Smolen JS, Blueml S Conference contribution POTENTIAL CELLULAR AND MOLECULAR TARGETS (2019) Distler J Conference contribution THE ANTI-RO52 PREVALENCE IN THE SJOGREN'S SYNDROME PICTURE: A SINGLE CENTER CROSS SECTIONAL STUDY (2019) Valor L, Schenker H, Hagen M, Knitza J, Rech J, Schett G Conference contribution FACTORS ASSOCIATED WITH PERSISTENT DRUG-FREE REMISSION IN PATIENTS WITH RHEUMATOID ARTHRITIS (2019) Valor L, Hagen M, Reiser M, Kleyer A, Hartmann F, Manger B, Schett G, et al. Conference contribution SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENT OF ENTHESITIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS: POOLED ANALYSIS OF FOUR PIVOTAL PHASE 3 STUDIES (2019) Schett G, Baraliakos X, Van Den Bosch F, Deodhar A, Gensler LS, Ostergaard M, Agawane S, et al. Conference contribution DUAL NEUTRALISATION OF IL-17A AND IL-17F WITH BIMEKIZUMAB IN PATIENTS WITH ACTIVE PSA: OVERALL AND TNF-INHIBITOR-NAIVE POPULATION RESULTS FROM A 48-WEEK PHASE 2B RANDOMISED STUDY (2019) Ritchlin CT, Kavanaugh A, Merola JF, Schett G, Scher JU, Warren RB, Assudani D, et al. Conference contribution